Literature DB >> 30811296

Gonadal Functioning and Perceptions of Infertility Risk Among Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study.

Vicky Lehmann1, Wassim Chemaitilly1, Lu Lu1, Daniel M Green1, William H Kutteh1,2, Tara M Brinkman1, Deo Kumar Srivastava1, Leslie L Robison1, Melissa M Hudson1, James L Klosky1.   

Abstract

PURPOSE: To describe perceptions of infertility risk among adult survivors of childhood cancer, to test the concordance of survivors' risk perceptions and their adult fertility status, and to identify explanatory factors (sociodemographic factors, gonadotoxic treatments, reproductive history, sexual dysfunction) associated with these outcomes. PATIENTS AND METHODS: Adult childhood cancer survivors (N = 1,067; without children or a history of pregnancies) completed questionnaires that asked about infertility risk perceptions and participated in physical evaluations, including biomarkers of gonadal functioning (eg, semen analysis, blood hormone levels, menses). Multivariable regression models tested associations between explanatory factors and risk perceptions as well as concordance of perceptions and fertility status.
RESULTS: Most childhood cancer survivors (61.9%) perceived themselves at increased risk for infertility, which was significantly associated with sociodemographic factors (older age, white ethnicity, being married/partnered, higher education), gonadotoxic treatments, fertility concerns, previous unsuccessful attempts to conceive, and sexual dysfunction (all P < .05). Laboratory-evaluated impaired gonadal function was found in 24.3% of female and 55.6% of male survivors, but concordance with survivors' risk perceptions was low (Cohen's κ < .19). Most survivors with discordant perceptions overestimated risk (ie, perceived being at risk, though fertility status seemed normal; 19.7% of male and 43.6% of female survivors), whereas a minority underestimated risk (ie, perceived no risk but were impaired/infertile; 16.3% of male and 5.3% of female survivors). Factors related to discordance included sociodemographics, gonadotoxic treatments, fertility concerns, and sexual dysfunction (all P < .05).
CONCLUSION: Although childfree survivors may correctly consider themselves at risk for infertility on the basis of their previous treatments, such risk perceptions were discordant from laboratory-evaluated fertility status among many survivors in adulthood. Thus, repeated fertility-related communication throughout survivorship is essential, because treatment-indicated risk does not equal fertility status after treatment. Offering fertility testing to those who were at risk and/or those with fertility-related concerns is recommended.

Entities:  

Mesh:

Year:  2019        PMID: 30811296      PMCID: PMC6455717          DOI: 10.1200/JCO.18.00965

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  10 in total

1.  Optimizing health literacy to facilitate reproductive health decision-making in adolescent and young adults with cancer.

Authors:  Leena Nahata; Antoinette Anazodo; Brooke Cherven; Shanna Logan; Lillian R Meacham; Cathy D Meade; Sara Zarnegar-Lumley; Gwendolyn P Quinn
Journal:  Pediatr Blood Cancer       Date:  2020-07-06       Impact factor: 3.167

2.  Attitudes and Perceptions of Parenthood Among Young Adult Survivors of Childhood Cancer.

Authors:  Alexandra C Himelhoch; Taylor M Datillo; Marrit A Tuinman; Cynthia A Gerhardt; Vicky Lehmann
Journal:  J Adolesc Young Adult Oncol       Date:  2021-05-17       Impact factor: 2.223

Review 3.  Testosterone Use in Adolescent Males: Current Practice and Unmet Needs.

Authors:  Maria Vogiatzi; James P Tursi; Jonathan S Jaffe; Sue Hobson; Alan D Rogol
Journal:  J Endocr Soc       Date:  2020-10-30

Review 4.  Female Oncofertility: Current Understandings, Therapeutic Approaches, Controversies, and Future Perspectives.

Authors:  Kim Cat Tuyen Vo; Kazuhiro Kawamura
Journal:  J Clin Med       Date:  2021-12-03       Impact factor: 4.241

Review 5.  Puberty Induction in Adolescent Males: Current Practice.

Authors:  Mohammed S Alenazi; Ali M Alqahtani; Mohammad M Ahmad; Eyad M Almalki; Angham AlMutair; Mussa Almalki
Journal:  Cureus       Date:  2022-04-05

6.  Late effects and survival of children with malignant solid tumours in northern Finland: a single-centre cohort study.

Authors:  Sanni Kortelainen; Tekla Harju; Hanna Juntti; Tytti Pokka; Riitta Niinimäki
Journal:  Eur J Pediatr       Date:  2022-02-24       Impact factor: 3.860

7.  White paper: Oncofertility in pediatric patients with Wilms tumor.

Authors:  M E Madeleine van der Perk; Nicholas G Cost; Annelies M E Bos; Robert Brannigan; Tanzina Chowdhury; Andrew M Davidoff; Najat C Daw; Jeffrey S Dome; Peter Ehrlich; Norbert Graf; James Geller; John Kalapurakal; Kathleen Kieran; Marcus Malek; Mary F McAleer; Elizabeth Mullen; Luke Pater; Angela Polanco; Rodrigo Romao; Amanda F Saltzman; Amy L Walz; Andrew D Woods; Marry M van den Heuvel-Eibrink; Conrad V Fernandez
Journal:  Int J Cancer       Date:  2022-05-11       Impact factor: 7.316

8.  Study protocol for the Fex-Can Childhood project: An observational study and a randomized controlled trial focusing on sexual dysfunction and fertility-related distress in young adult survivors of childhood cancer.

Authors:  Lisa Ljungman; Poorna Anandavadivelan; Kirsi Jahnukainen; Claudia Lampic; Lena Wettergren
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

9.  Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.

Authors:  Jennifer S Walsh; Helen Marshall; Isabelle L Smith; Diana M Greenfield; Jayne Swain; Emma Best; James Ashton; Julia M Brown; Robert Huddart; Robert E Coleman; John A Snowden; Richard J Ross
Journal:  PLoS Med       Date:  2019-11-12       Impact factor: 11.069

10.  Health outcomes in offspring born to survivors of childhood cancers following assisted reproductive technologies.

Authors:  Greta Sommerhäuser; Anja Borgmann-Staudt; Kathy Astrahantseff; Katja Baust; Gabriele Calaminus; Ralf Dittrich; Marta J Fernández-González; Heike Hölling; Charlotte J König; Ralph Schilling; Theresa Schuster; Laura Lotz; Magdalena Balcerek
Journal:  J Cancer Surviv       Date:  2020-08-26       Impact factor: 4.442

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.